MX2022013681A - Metodos y composiciones para el tratamiento de la hipercalciuria y la nefrolitiasis. - Google Patents

Metodos y composiciones para el tratamiento de la hipercalciuria y la nefrolitiasis.

Info

Publication number
MX2022013681A
MX2022013681A MX2022013681A MX2022013681A MX2022013681A MX 2022013681 A MX2022013681 A MX 2022013681A MX 2022013681 A MX2022013681 A MX 2022013681A MX 2022013681 A MX2022013681 A MX 2022013681A MX 2022013681 A MX2022013681 A MX 2022013681A
Authority
MX
Mexico
Prior art keywords
hypercalciuria
nephrolithiasis
compositions
methods
treatment
Prior art date
Application number
MX2022013681A
Other languages
English (en)
Inventor
Eduardo I Canto
Original Assignee
Ana Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ana Pharmaceuticals Inc filed Critical Ana Pharmaceuticals Inc
Publication of MX2022013681A publication Critical patent/MX2022013681A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/15—Vitamins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/194—Carboxylic acids, e.g. valproic acid having two or more carboxyl groups, e.g. succinic, maleic or phthalic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4415—Pyridoxine, i.e. Vitamin B6
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A61K33/08—Oxides; Hydroxides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/04—Drugs for disorders of the urinary system for urolithiasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nutrition Science (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Mycology (AREA)
  • Inorganic Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Pediatric Medicine (AREA)
  • Rheumatology (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)

Abstract

Se describen métodos, composiciones y formulaciones para tratar o prevenir la hipercalciuria, reduciendo así el riesgo de nefrolitiasis y normalizando la composición química y la composición de la orina. El método incluye administrar vitamina K2 en una composición medicinal o nutricional, preferiblemente sin calcio, opcionalmente en combinación con una dosis terapéutica de uno o más seleccionados del grupo que consiste en: una sal de citrato, óxido de magnesio, una sal de bicarbonato y vitamina B6.
MX2022013681A 2016-06-02 2018-11-30 Metodos y composiciones para el tratamiento de la hipercalciuria y la nefrolitiasis. MX2022013681A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201662344653P 2016-06-02 2016-06-02

Publications (1)

Publication Number Publication Date
MX2022013681A true MX2022013681A (es) 2022-12-13

Family

ID=60479095

Family Applications (2)

Application Number Title Priority Date Filing Date
MX2018014933A MX2018014933A (es) 2016-06-02 2017-06-01 Metodos y composiciones para el tratamiento de la hipercalciuria y la nefrolitiasis.
MX2022013681A MX2022013681A (es) 2016-06-02 2018-11-30 Metodos y composiciones para el tratamiento de la hipercalciuria y la nefrolitiasis.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
MX2018014933A MX2018014933A (es) 2016-06-02 2017-06-01 Metodos y composiciones para el tratamiento de la hipercalciuria y la nefrolitiasis.

Country Status (14)

Country Link
US (1) US20200315233A1 (es)
EP (1) EP3463322A4 (es)
JP (2) JP2019517482A (es)
AU (1) AU2017274438A1 (es)
BR (1) BR112018075067A2 (es)
CA (1) CA3026143A1 (es)
CO (1) CO2018013999A2 (es)
CR (1) CR20180576A (es)
DO (1) DOP2018000265A (es)
EC (1) ECSP19000167A (es)
MX (2) MX2018014933A (es)
NI (1) NI201800126A (es)
TW (1) TW201808271A (es)
WO (1) WO2017210467A1 (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109806225B (zh) * 2019-03-16 2021-06-01 西安安健药业有限公司 维生素k1脂肪乳注射液
CN112438967A (zh) * 2019-08-27 2021-03-05 高兵 维生素k在制备泌尿系结石防治药物和保健品中的应用

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4446024C2 (de) * 1994-12-22 1997-01-23 Bartz Volker Verwendung eines Vitamins der K-Gruppe
GT199800126A (es) * 1997-08-29 2000-01-29 Terapia de combinacion.
CN1322530A (zh) * 2000-05-09 2001-11-21 詹炳炎 一种防治泌尿系结石的药物——尿石净
WO2003009704A2 (en) * 2001-07-27 2003-02-06 N.V. Nutricia Enteral compositions for the prevention and/or treatment of sepsis
US20050233461A1 (en) * 2002-06-05 2005-10-20 Douglas Levinson High-throughput methods and systems for screening of compounds to treat/prevent kidney disorders
US8703209B2 (en) * 2003-06-17 2014-04-22 Edward Larry McCleary Composition and method for modulating hydrogen ion physiology
US20080220094A1 (en) * 2006-11-01 2008-09-11 Wyeth Compositions and methods for the treatment and/or prevention of osteoporosis
BRPI0812686A2 (pt) * 2007-07-24 2011-10-18 Viridis Biopharma Pvt Ltd meios de aplicação de análogos da vitamina k e derivados para o tratamento de condições de doença humana e distúrbios
MX2012003080A (es) * 2009-09-14 2012-04-19 Nestec Sa Composiciones nutricionales para modular la inflamacion que incluyen vitamina k2 exogena.
US20110229587A1 (en) * 2009-09-24 2011-09-22 Algaecal Distribution Inc. Calcium Supplements for the Treatment of Diabetes
EP2601168A4 (en) * 2010-08-06 2013-12-04 Ampere Life Sciences Inc TREATMENT OF MITOCHONDRIAL DISEASES BY VITAMIN K
WO2012170773A1 (en) * 2011-06-08 2012-12-13 Edison Pharmaceuticals, Inc. Adjunctive therapy for the treatment of mitochondrial disorders with quinones and naphthoquinones
US20150359807A1 (en) * 2014-06-11 2015-12-17 Supernutrition Life-Extension Research, Inc. Dietary Supplement Containing Vitamin A, D3 and Vitamin K2 and Uses Thereof

Also Published As

Publication number Publication date
DOP2018000265A (es) 2019-04-30
US20200315233A1 (en) 2020-10-08
TW201808271A (zh) 2018-03-16
ECSP19000167A (es) 2019-01-31
MX2018014933A (es) 2019-04-09
AU2017274438A1 (en) 2018-12-13
EP3463322A4 (en) 2019-11-20
CO2018013999A2 (es) 2019-03-08
NI201800126A (es) 2019-03-28
JP2022153651A (ja) 2022-10-12
EP3463322A1 (en) 2019-04-10
CA3026143A1 (en) 2017-12-07
WO2017210467A1 (en) 2017-12-07
JP2019517482A (ja) 2019-06-24
BR112018075067A2 (pt) 2019-04-30
CR20180576A (es) 2019-04-09

Similar Documents

Publication Publication Date Title
SG10201811185YA (en) Pharmaceutical composition for use in prevention and/or treatment of disease that develops or progresses as a result of decrease or loss of activity of blood coagulation factor viii and/or activated blood coagulation factor viii
WO2018084531A3 (ko) 골 질환, 비만 및 지질 관련 대사성 질환의 예방 또는 치료용 조성물
PH12018502634A1 (en) Topical compositions of apremilast
MX2013000319A (es) Tratamiento de transtornos cognitivos.
MX365366B (es) Formulaciones tópicas y orales que comprenden taurina y magnesio para la prevención y el tratamiento del acné.
MX2020011737A (es) Metodos de tratamiento con vitamina d.
MX2022011372A (es) Composiciones de zinc-y-pga y metodos para tratar el cancer.
PH12016502233A1 (en) (s)-pirlindole or its pharmaceutically acceptable salts for use in medicine
MX2022013681A (es) Metodos y composiciones para el tratamiento de la hipercalciuria y la nefrolitiasis.
MX2019003751A (es) Proteina terapeutica.
BR112016029437A2 (pt) métodos para tratamento e prevenção de doenças de instabilidade vascular
MX2016016400A (es) Formulaciones de oximetazolina estabilizadas y sus usos.
NZ754706A (en) Use of lactic acid bacteria to treat or prevent gestational diabetes mellitus
IN2014DN09240A (es)
WO2015165964A8 (en) Treatment and prevention of alzheimer's disease (ad)
MX2020001217A (es) Metodos de tratamiento de sintomas de gastroparesia usando velusetrag.
PH12020500606A1 (en) Use of functionalized calcium carbonate as active ingredient
PH12016502107A1 (en) Combination of brexpiprazole and nalmefene and use thereof for treating substance-related disorders
BR112018002433A2 (pt) composição farmacêutica para tratamento da enxaqueca
MX2021005950A (es) Formulaciones pediatricas acuosas de retinol.
UA118696U (uk) Спосіб лікування дітей з розладами аутистичного спектру
PL3246032T3 (pl) Kompozycje farmaceutyczne z kwasem zoledronowym, wapniem i witaminą d, odpowiednie do leczenia i/lub profilaktyki chorób metabolicznych kości oraz działań ubocznych spowodowanych terapią, takich jak hipokalcemia
WO2018154608A3 (en) Herbo-mineral formulation for the treatment of cardio vascular diseases and method of preparation thereof
UA97257U (uk) Спосіб профілактики та лікування серцево-судинних захворювань
MD918Z (ro) Metodă de tratament al meningitei enterovirale la copii